Granite Games

Granite Bio is a Swiss biotechnology company focused on developing targeted monoclonal antibody therapies for patients suffering from autoimmune and inflammatory diseases. Launched in 2022 as a venture-backed startup, the company leverages a discovery engine to identify and validate novel targets in the inflammation and fibrosis space. Its lead programs aim to address significant unmet medical needs by modulating immune pathways with high specificity. Granite Bio operates primarily in a stealth or semi-stealth mode, focusing on the early-stage development of its proprietary pipeline. The company is supported by prominent life science investors and is headquartered in the global biotech hub of Basel.